YKL40 in Sporadic Amyotrophic Lateral Sclerosis: Cerebrospinal Fluid Levels as a Prognosis Marker of Disease Progression

Aging - United States
doi 10.18632/aging.101551
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Impact Journals, LLC

Related search

Proteomic Analysis of Cerebrospinal Fluid in Amyotrophic Lateral Sclerosis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

The Longitudinal Cerebrospinal Fluid Metabolomic Profile of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
MedicineNeurology
2015English

Proteomic Profiling of Cerebrospinal Fluid Identifies Biomarkers for Amyotrophic Lateral Sclerosis

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2005English

Pathogenic Mechanisms in Sporadic Amyotrophic Lateral Sclerosis

Canadian Journal of Neurological Sciences
MedicineNeurology
1993English

Increased Interleukin-6 Levels in the Astrocyte-Derived Exosomes of Sporadic Amyotrophic Lateral Sclerosis Patients

Frontiers in Neuroscience
Neuroscience
2019English

Lipids, Apolipoproteins, and Prognosis of Amyotrophic Lateral Sclerosis

Neurology
Neurology
2020English

TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis

PLoS ONE
Multidisciplinary
2008English

Bright Tongue Sign: A Diagnostic Marker for Amyotrophic Lateral Sclerosis

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2014English

Body Weight Variation Predicts Disease Progression After Invasive Ventilation in Amyotrophic Lateral Sclerosis

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy